Start | Browse by Day | Author Index

117 Maximum tolerated dose of silodosin, a highly selective alpha-1A-adrenoceptor antagonist, for the treatment of symptoms associated with benign prostatic hyperplasia

Sunday, April 26, 2009
Lawrence A. Hill, PharmD , Watson Laboratories, Salt Lake City, UT
Weining Volinn, MS , Watson Laboratories, Salt Lake City, UT
Gary Hoel, RPh, PhD , Watson Laboratories, Salt Lake City, UT
See more of: Scientific Poster Presentation II
See more of: Original Research
<< Previous Abstract | Next Abstract >>